T1	Pharmacodynamic_phenotype	28 47	acquired resistance
T2	Gene_or_protein	70 138	epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitors
T3	Chemical	70 140	epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitors (
T4	Chemical	143 150	I ) for
T5	Disease	174 195	mutant lung cancers .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	influences	Arg1:T2	Arg2:T3
R6	treats	Arg1:T2	Arg2:T4
R7	treats	Arg1:T2	Arg2:T5
R8	treats	Arg1:T3	Arg2:T1
R9	isEquivalentTo	Arg1:T3	Arg2:T2
R10	treats	Arg1:T3	Arg2:T4
R11	treats	Arg1:T3	Arg2:T5
R12	isEquivalentTo	Arg1:T4	Arg2:T2
R13	isEquivalentTo	Arg1:T4	Arg2:T3
R14	treats	Arg1:T4	Arg2:T5
R15	isAssociatedWith	Arg1:T5	Arg2:T1
R16	isAssociatedWith	Arg1:T5	Arg2:T4
